Reeves HL - Search Results

1

DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.

Cornell L, Munck JM, Alsinet C, Villanueva A, Ogle L, Willoughby CE, Televantou D, Thomas HD, Jackson J, Burt AD, Newell D, Rose J, Manas DM, Shapiro GI, Curtin NJ, Reeves HL. Cornell L, et al. Among authors: reeves hl. Clin Cancer Res. 2015 Feb 15;21(4):925-33. doi: 10.1158/1078-0432.CCR-14-0842. Epub 2014 Dec 5. Clin Cancer Res. 2015. PMID: 25480831 Free PMC article.

2

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

3

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

Reeves HL, Francis RM, Manas DM, Hudson M, Day CP. Reeves HL, et al. Liver Transpl Surg. 1998 Sep;4(5):404-9. doi: 10.1002/lt.500040508. Liver Transpl Surg. 1998. PMID: 9724478 Free article.

4

The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells.

Reeves HL, Thompson MG, Dack CL, Burt AD, Day CP. Reeves HL, et al. Hepatology. 2000 Jan;31(1):95-100. doi: 10.1002/hep.510310116. Hepatology. 2000. PMID: 10613733

5

Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture.

Reeves HL, Dack CL, Peak M, Burt AD, Day CP. Reeves HL, et al. J Hepatol. 2000 Mar;32(3):465-72. doi: 10.1016/s0168-8278(00)80398-0. J Hepatol. 2000. PMID: 10735617

6

The development of targeted therapies for hepatocellular cancer.

Chattopadhyay D, Manas DM, Reeves HL. Chattopadhyay D, et al. Among authors: reeves hl. Curr Pharm Des. 2007;13(32):3292-300. doi: 10.2174/138161207782360717. Curr Pharm Des. 2007. PMID: 18045181 Review.

7

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.

Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H. Beale G, et al. BMC Cancer. 2008 Jul 18;8:200. doi: 10.1186/1471-2407-8-200. BMC Cancer. 2008. PMID: 18638391 Free PMC article.

8

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.

Gray J, Chattopadhyay D, Beale GS, Patman GL, Miele L, King BP, Stewart S, Hudson M, Day CP, Manas DM, Reeves HL. Gray J, et al. Among authors: reeves hl. BMC Cancer. 2009 Aug 5;9:271. doi: 10.1186/1471-2407-9-271. BMC Cancer. 2009. PMID: 19656391 Free PMC article.

9

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

Llovet JM, Peña CE, Lathia CD, Shan M, Meinhardt G, Bruix J; SHARP Investigators Study Group. Llovet JM, et al. Clin Cancer Res. 2012 Apr 15;18(8):2290-300. doi: 10.1158/1078-0432.CCR-11-2175. Epub 2012 Feb 28. Clin Cancer Res. 2012. PMID: 22374331 Free article. Clinical Trial.

10

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.

Dyson J, Jaques B, Chattopadyhay D, Lochan R, Graham J, Das D, Aslam T, Patanwala I, Gaggar S, Cole M, Sumpter K, Stewart S, Rose J, Hudson M, Manas D, Reeves HL. Dyson J, et al. Among authors: reeves hl. J Hepatol. 2014 Jan;60(1):110-7. doi: 10.1016/j.jhep.2013.08.011. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters